XORTX Therapeutics Inc (TSE:XRTX) has released an update.
XORTX Therapeutics Inc. reported a decrease in total assets to $3.85 million as of September 30, 2024, compared to $5.47 million at the end of 2023, alongside an increased derivative warrant liability. The company’s current liabilities rose significantly, highlighting financial challenges amid ongoing research and development expenses.
For further insights into TSE:XRTX stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Deutsche Bank Pounds the Table on Tesla Stock
- ‘Breath of Fresh Air,’ Says Daniel Ives About Rivian Stock
- ‘It’s Not Too Late to Load Up,’ Says Analyst About Nvidia Stock
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.